首页 > 最新文献

Value in Health最新文献

英文 中文
Incorporating Informal Caregiving Time Into Cost-Effectiveness Analysis for Adults Aged 50 and Older: Estimating From Health-Related Quality of Life and Functional Status 将非正式护理时间纳入50岁及以上成年人的成本-效果分析:从健康相关生活质量和功能状态估计
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.07.026
Boshen Jiao PhD, MPH , Xinran Lu MS , Darius N. Lakdawalla PhD , William V. Padula PhD , Fangli Geng PhD, MS

Objectives

Informal caregiving, often provided by family and friends, is essential for supporting individuals with functional impairments. However, these caregiving costs are frequently excluded from cost-effectiveness analyses (CEAs), potentially biasing the evaluation of medical interventions dependent on informal caregiving. Although guidelines recommend including these costs in CEA from a societal perspective, implementation has been inconsistent because of limited data. To address this gap, we developed US-based models estimating informal caregiving time by linking it to health-related quality of life (HrQoL) of care recipients.

Methods

Using data from the 2010 to 2018 waves of the Health and Retirement Study, a nationally representative survey of Americans aged 50+, we focused on individuals with limitations in activities of daily living (ADLs) or instrumental ADLs (IADLs). We performed regression analyses to estimate the association between informal caregiving time and HrQoL, developing separate models with and without ADL/IADL predictors. Additionally, we created models with both preference-based health utility scores from the Health Utilities Index Mark 3 and visual analog scale scores as the HrQoL measures.

Results

The models demonstrated strong predictive accuracy based on cross-validation. Findings from the models using HrQoL as the primary predictor indicate that lower Health Utilities Index or visual analog scale scores are associated with increased caregiving time. The models incorporating the number of ADL and IADL limitations as additional predictors further highlight the growing demand for informal caregiving as functional impairments worsen.

Conclusions

These models provide practical tools to facilitate the inclusion of informal caregiving costs in US-based CEAs.
目的:通常由家人和朋友提供的非正式照料对于支持有功能障碍的个人至关重要。然而,这些护理费用经常被排除在成本效益分析(cea)之外,这可能会对依赖于非正式护理的医疗干预措施的评估产生偏见。尽管指南建议从社会角度将这些成本包括在CEA中,但由于数据有限,实施一直不一致。为了解决这一差距,我们开发了基于美国的模型,通过将非正式护理时间与护理对象的健康相关生活质量(HrQoL)联系起来,来估计非正式护理时间。方法:使用2010-2018年健康与退休研究(HRS)的数据,这是一项针对50岁以上美国人的全国代表性调查,我们重点关注日常生活活动(ADLs)或工具性ADLs (IADLs)受限的个体。我们进行了回归分析,以估计非正式护理时间与HrQoL之间的关系,并开发了单独的模型,包括ADL/IADL预测因子和不包括ADL/IADL预测因子。此外,我们创建了基于健康效用指数(HUI)标记3的基于偏好的健康效用评分和视觉模拟量表(VAS)评分作为HrQoL测量的模型。结果:基于交叉验证的模型显示出较强的预测准确性。使用HrQoL作为主要预测因子的模型结果表明,较低的HUI或VAS评分与护理时间的增加有关。将ADL和IADL限制数量作为额外预测因素的模型进一步强调,随着功能障碍的恶化,对非正式护理的需求日益增长。结论:这些模型提供了实用的工具,有助于在美国的cea中纳入非正式护理成本。
{"title":"Incorporating Informal Caregiving Time Into Cost-Effectiveness Analysis for Adults Aged 50 and Older: Estimating From Health-Related Quality of Life and Functional Status","authors":"Boshen Jiao PhD, MPH ,&nbsp;Xinran Lu MS ,&nbsp;Darius N. Lakdawalla PhD ,&nbsp;William V. Padula PhD ,&nbsp;Fangli Geng PhD, MS","doi":"10.1016/j.jval.2025.07.026","DOIUrl":"10.1016/j.jval.2025.07.026","url":null,"abstract":"<div><h3>Objectives</h3><div>Informal caregiving, often provided by family and friends, is essential for supporting individuals with functional impairments. However, these caregiving costs are frequently excluded from cost-effectiveness analyses (CEAs), potentially biasing the evaluation of medical interventions dependent on informal caregiving. Although guidelines recommend including these costs in CEA from a societal perspective, implementation has been inconsistent because of limited data. To address this gap, we developed US-based models estimating informal caregiving time by linking it to health-related quality of life (HrQoL) of care recipients.</div></div><div><h3>Methods</h3><div>Using data from the 2010 to 2018 waves of the Health and Retirement Study, a nationally representative survey of Americans aged 50+, we focused on individuals with limitations in activities of daily living (ADLs) or instrumental ADLs (IADLs). We performed regression analyses to estimate the association between informal caregiving time and HrQoL, developing separate models with and without ADL/IADL predictors. Additionally, we created models with both preference-based health utility scores from the Health Utilities Index Mark 3 and visual analog scale scores as the HrQoL measures.</div></div><div><h3>Results</h3><div>The models demonstrated strong predictive accuracy based on cross-validation. Findings from the models using HrQoL as the primary predictor indicate that lower Health Utilities Index or visual analog scale scores are associated with increased caregiving time. The models incorporating the number of ADL and IADL limitations as additional predictors further highlight the growing demand for informal caregiving as functional impairments worsen.</div></div><div><h3>Conclusions</h3><div>These models provide practical tools to facilitate the inclusion of informal caregiving costs in US-based CEAs.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 82-91"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144804883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toward a Common Ground for Defining Digital Health Interventions, Mapping Digital Health Frameworks to PICOTS-ComTeC: An ISPOR Special Interest Group Report 迈向定义数字健康干预措施的共同基础,将数字健康框架映射到picot - comtec: ISPOR特别兴趣小组报告。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.07.022
Annette Champion MBA , Anita Burrell MA , Anke-Peggy Holtorf PhD , Rossella Di Bidino PhD , Jagadeswara Rao Earla PhD , Artem T. Boltyenkov PhD , Masami Tabata-Kelly MA , Carl Asche PhD , Brian Seal PhD , Zsombor Zrubka PhD

Objectives

Digital health interventions (DHIs) should be defined in a comparable, structured manner to facilitate research informing clinical and financial decisions. The Population, Intervention, Comparator, Outcomes, Timing, Setting, Communication, Technology, Context (PICOTS-ComTeC) framework was developed to define patient-facing DHIs for health economics and outcomes research. Our objective was to compare PICOTS-ComTeC with established DHI frameworks and guidelines to determine the degree of overlap, additional value of PICOTS-ComTeC, and how the frameworks might be used together.

Methods

An expert group selected comparator frameworks. Reviewer pairs extracted information and mapped DHI definitions to 9 domains and 32 subcategories of PICOTS-ComTeC. A third reviewer checked for consistency across frameworks and missing data.

Results

A diverse group of 16 frameworks (9 international, regarding DHI classification, quality, labeling, and reporting; 6 national DHI health technology assessment and payer; 1 international health economic reporting) were compared with PICOTS-ComTeC. Across all frameworks, 81% (116/144) of PICOTS-ComTeC domains matched (range 44%-100%). The mean number of domain matches for a framework was 7.3. Comparator frameworks matched 48% (247/512) of PICOTS-ComTeC subcategories (range 16%-81%).

Conclusions

The degree to which PICOTS-ComTeC is congruous with items in diverse DHI frameworks suggests that PICOTS-ComTeC represents a common ground for defining patient-facing DHIs for research, reporting, and assessment purposes, thereby improving patient care by accelerating adoption of effective DHIs. PICOTS-ComTeC contains items not uniformly present in comparator frameworks. PICOTS-ComTeC can be used to define patient-facing DHIs by adding missing PICOTS-ComTeC items to comparator frameworks or using information from comparator frameworks to describe PICOTS-ComTeC items.
目标:应以可比较的、结构化的方式定义数字卫生干预措施(DHIs),以促进为临床和财务决策提供信息的研究。PICOTS-ComTeC(人口、干预、比较、结果、时间、设置、沟通、技术、环境)框架被开发用于定义面向患者的DHIs,用于卫生经济学和结果研究。我们的目标是比较PICOTS-ComTeC与已建立的DHI框架和指南,以确定重叠的程度,PICOTS-ComTeC的附加价值,以及如何将这些框架一起使用。方法:专家组选择比较框架。审稿人对提取信息并将DHI定义映射到PICOTS-ComTeC的9个域和32个子类别。第三个审稿人检查了框架之间的一致性和丢失的数据。结果:16个框架(9个国际框架,关于DHI分类、质量、标签和报告;6 .国家卫生技术评估与支付人;一份国际卫生经济报告)与PICOTS-ComTeC进行比较。在所有框架中,81%(116/144)的PICOTS-ComTeC域匹配(范围为44%-100%)。一个框架的平均域匹配数为7.3。比较框架匹配48%(247/512)的PICOTS-ComTeC子类别(范围16%-81%)。结论:PICOTS-ComTeC与不同DHI框架项目的一致程度表明,PICOTS-ComTeC代表了为研究、报告和评估目的定义面向患者的DHIs的共同基础,从而通过加速采用有效的DHIs来改善患者护理。PICOTS-ComTeC包含的项目在比较器框架中并不统一。PICOTS-ComTeC可用于定义面向患者的DHIs,方法是将缺少的PICOTS-ComTeC项目添加到比较器框架中,或者使用比较器框架中的信息来描述PICOTS-ComTeC项目。
{"title":"Toward a Common Ground for Defining Digital Health Interventions, Mapping Digital Health Frameworks to PICOTS-ComTeC: An ISPOR Special Interest Group Report","authors":"Annette Champion MBA ,&nbsp;Anita Burrell MA ,&nbsp;Anke-Peggy Holtorf PhD ,&nbsp;Rossella Di Bidino PhD ,&nbsp;Jagadeswara Rao Earla PhD ,&nbsp;Artem T. Boltyenkov PhD ,&nbsp;Masami Tabata-Kelly MA ,&nbsp;Carl Asche PhD ,&nbsp;Brian Seal PhD ,&nbsp;Zsombor Zrubka PhD","doi":"10.1016/j.jval.2025.07.022","DOIUrl":"10.1016/j.jval.2025.07.022","url":null,"abstract":"<div><h3>Objectives</h3><div>Digital health interventions (DHIs) should be defined in a comparable, structured manner to facilitate research informing clinical and financial decisions. The Population, Intervention, Comparator, Outcomes, Timing, Setting, Communication, Technology, Context (PICOTS-ComTeC) framework was developed to define patient-facing DHIs for health economics and outcomes research. Our objective was to compare PICOTS-ComTeC with established DHI frameworks and guidelines to determine the degree of overlap, additional value of PICOTS-ComTeC, and how the frameworks might be used together.</div></div><div><h3>Methods</h3><div>An expert group selected comparator frameworks. Reviewer pairs extracted information and mapped DHI definitions to 9 domains and 32 subcategories of PICOTS-ComTeC. A third reviewer checked for consistency across frameworks and missing data.</div></div><div><h3>Results</h3><div>A diverse group of 16 frameworks (9 international, regarding DHI classification, quality, labeling, and reporting; 6 national DHI health technology assessment and payer; 1 international health economic reporting) were compared with PICOTS-ComTeC. Across all frameworks, 81% (116/144) of PICOTS-ComTeC domains matched (range 44%-100%). The mean number of domain matches for a framework was 7.3. Comparator frameworks matched 48% (247/512) of PICOTS-ComTeC subcategories (range 16%-81%).</div></div><div><h3>Conclusions</h3><div>The degree to which PICOTS-ComTeC is congruous with items in diverse DHI frameworks suggests that PICOTS-ComTeC represents a common ground for defining patient-facing DHIs for research, reporting, and assessment purposes, thereby improving patient care by accelerating adoption of effective DHIs. PICOTS-ComTeC contains items not uniformly present in comparator frameworks. PICOTS-ComTeC can be used to define patient-facing DHIs by adding missing PICOTS-ComTeC items to comparator frameworks or using information from comparator frameworks to describe PICOTS-ComTeC items.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 1-13"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144800399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of Value Set Choice on EQ-5D-Y-3L Child and Proxy Health-Related Quality of Life Ratings: What to Do When a Country-Specific “Y” Value Set Is Unavailable? 值集选择对EQ-5D-Y-3L儿童和代理HRQoL评分的影响:当国家特定的“Y”值集不可用时该怎么办?
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.08.004
Diana Khanna PhD , Jyoti Khadka PhD , Christine Mpundu-Kaambwa PhD , Rachel Milte PhD , Julie Ratcliffe PhD , Quality of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA) project team

Objectives

There is limited guidance on whether to apply an available EQ-5D-Y-3L “Y” value set from another country or use a country-specific EQ-5D-3L “adult” value set when a country-specific “Y” value set is unavailable. This study aims to examine how the choice of value set (ie, “Y” or “adult”) influences the interrater gap between child-self and proxy-reported health-related quality of life (HRQoL).

Methods

An online sample of 845 dyads (children aged 6-10 years and parents) independently completed the self and proxy versions of the EQ-5D-Y-3L. Corresponding HRQoL values were derived using the “Y” and the “adult” value sets for 5 countries: Germany, Hungary, Japan, The Netherlands, and Spain. Analyses were stratified by age (6-7 vs 8-10-year-olds), gender (boys vs girls), and health condition (no vs yes). Group differences were identified using paired t tests. The percentage of directional consistency in child-proxy discrepancies across value sets was also examined as a secondary analysis.

Results

Proxies significantly overestimated HRQoL values across most “Y” value sets (Hungary, Japan, and Spain). Significant discrepancies using the corresponding “adult” value sets were observed only for Germany. Additionally, significant interrater differences were observed for children without health conditions across all value sets. Proportional agreement in direction was marginally higher when using “Y” value sets, except for Germany.

Conclusions

The choice of value set influences child-proxy HRQoL assessments. In the absence of a country-specific “Y” value set, using an alternative “Y” value set is preferable to relying solely on a country-specific “adult” value set.
目的:对于是否应用来自其他国家的可用EQ-5D-Y-3L“Y”值集,或者在无法获得特定国家的“Y”值集时使用特定国家的EQ-5D-3L“成人”值集,目前的指导有限。本研究旨在检验值集(即“Y”或“成人”)的选择如何影响儿童自我和代理报告的健康相关生活质量(HRQoL)之间的评分差距。方法:在线抽样845对(6-10岁儿童和家长)独立完成EQ-5D-Y-3L的自我版和代理版。相应的HRQoL值是使用“Y”和“成人”值集得出的,这五个国家是:德国、匈牙利、日本、荷兰和西班牙。分析按年龄(6-7岁vs 8-10岁)、性别和健康状况分层。使用配对t检验确定组间差异。跨值集的儿童代理差异的方向一致性百分比也作为次要分析进行了检查。结果:代理在大多数“Y”值集(匈牙利、日本、西班牙)中显著高估了HRQoL值。使用相应的“成人”值集,仅在德国观察到显著差异。此外,在所有值集中,对没有健康状况的儿童观察到显著的评分间差异。当使用“Y”值集时,除德国外,方向上的比例一致性略高。结论:值集的选择影响儿童代理HRQoL的评价。在没有特定国家的“Y”值集的情况下,使用替代的“Y”值集比完全依赖特定国家的“成人”值集更可取。
{"title":"Implications of Value Set Choice on EQ-5D-Y-3L Child and Proxy Health-Related Quality of Life Ratings: What to Do When a Country-Specific “Y” Value Set Is Unavailable?","authors":"Diana Khanna PhD ,&nbsp;Jyoti Khadka PhD ,&nbsp;Christine Mpundu-Kaambwa PhD ,&nbsp;Rachel Milte PhD ,&nbsp;Julie Ratcliffe PhD ,&nbsp;Quality of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA) project team","doi":"10.1016/j.jval.2025.08.004","DOIUrl":"10.1016/j.jval.2025.08.004","url":null,"abstract":"<div><h3>Objectives</h3><div>There is limited guidance on whether to apply an available EQ-5D-Y-3L “Y” value set from another country or use a country-specific EQ-5D-3L “adult” value set when a country-specific “Y” value set is unavailable. This study aims to examine how the choice of value set (ie, “Y” or “adult”) influences the interrater gap between child-self and proxy-reported health-related quality of life (HRQoL).</div></div><div><h3>Methods</h3><div>An online sample of 845 dyads (children aged 6-10 years and parents) independently completed the self and proxy versions of the EQ-5D-Y-3L. Corresponding HRQoL values were derived using the “Y” and the “adult” value sets for 5 countries: Germany, Hungary, Japan, The Netherlands, and Spain. Analyses were stratified by age (6-7 vs 8-10-year-olds), gender (boys vs girls), and health condition (no vs yes). Group differences were identified using paired <em>t</em> tests. The percentage of directional consistency in child-proxy discrepancies across value sets was also examined as a secondary analysis.</div></div><div><h3>Results</h3><div>Proxies significantly overestimated HRQoL values across most “Y” value sets (Hungary, Japan, and Spain). Significant discrepancies using the corresponding “adult” value sets were observed only for Germany. Additionally, significant interrater differences were observed for children without health conditions across all value sets. Proportional agreement in direction was marginally higher when using “Y” value sets, except for Germany.</div></div><div><h3>Conclusions</h3><div>The choice of value set influences child-proxy HRQoL assessments. In the absence of a country-specific “Y” value set, using an alternative “Y” value set is preferable to relying solely on a country-specific “adult” value set.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 119-128"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144970678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Generalized Risk-Adjusted Cost-Effectiveness Economic Model for Measuring the Value of Interventions That Delay Mobility Impairment Across Neurological Conditions 一个广义风险调整成本效益(GRACE)经济模型,用于测量延迟神经系统疾病的行动障碍干预的价值。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.08.006
Jason Shafrin PhD , Jaehong Kim PhD , Jacob Fajnor BA , Kyi-Sin Than MPH , Elizabeth S. Mearns PharmD , Stacey L. Kowal MSc , Thomas Majda PharmD , Jakub P. Hlávka PhD

Objectives

To quantify how incorporating patient risk preferences and severity adjustments affect the value of a hypothetical treatment for mobility impairments caused by neurological conditions.

Methods

A 5-state Markov model was developed to measure the health economic value of a hypothetical treatment delaying the progression of mobility impairments by 30.7% versus standard of care for patients who were 45-year-old, minimally impaired, and had received a diagnosis of a neurological condition. A generalized and risk-adjusted cost-effectiveness (GRACE) model was implemented using relative risk aversion estimates from a US general population survey. Treatment value was measured as risk-aversion and severity-adjusted net monetary benefit (NMB), defined as (1) risk-adjusted health gains (generalized risk-adjusted quality-adjusted life-years [GRA-QALYs]) monetized by (2) risk-aversion and severity-adjusted willingness to pay less (3) incremental costs. Risk-neutral results (traditional cost-effectiveness analysis [TCEA]) were compared.

Results

Incorporating risk preferences and disease severity increased the value of health benefits. Incremental health gains from using the hypothetical treatment (vs standard of care) were valued more when accounting for risk preferences with GRACE (1.358 GRA-QALYs vs 1.199 QALY). Willingness to pay for these health gains was higher when computed under GRACE compared with TCEA ($109 656 per GRA-QALY vs $100 000 per QALY). Overall, NMB increased by 11.6% (risk-aversion and severity-adjusted NMB = $278 324 vs TCEA NMB = $249 311) using GRACE versus TCEA. Results were sensitive to risk-aversion estimates and the functional form of patient utility.

Conclusions

In the first application of GRACE within neurology, GRACE increased the health economic value of a hypothetical neurology treatment, suggesting that TCEA may undervalue treatments for mobility-related neurological impairments.
目的:量化纳入患者风险偏好和严重程度调整如何影响神经系统疾病引起的活动障碍的假设治疗价值。方法:建立了一个五状态马尔可夫模型来衡量一种假设的治疗方法的健康经济价值,这种治疗方法比标准护理(SoC)延迟30.7%的运动障碍进展,诊断为神经系统疾病的45岁轻度损伤患者。使用来自美国普通人群调查的相对风险厌恶(RRA)估计,实现了广义和风险调整成本效益(GRACE)模型。治疗价值以风险厌恶和严重程度调整后的净货币效益(RASA-NMB)来衡量,定义为:(i)风险调整后的健康收益(GRA-QALYs)货币化(ii)风险厌恶和严重程度调整后的支付意愿(RASA-WTP)减去(iii)增量成本。风险中性结果(传统成本效益分析(TCEA))进行比较。结果:纳入风险偏好和疾病严重程度增加了健康益处的价值。当考虑GRACE的风险偏好时,使用假设治疗(vs. SoC)的增量健康收益更有价值(1.358 gra -QALY vs. 1.199 QALY)。与TCEA相比,GRACE下计算这些健康收益的支付意愿更高(每个GRA-QALY为109,656美元,每个QALY为100,000美元)。总体而言,使用GRACE与TCEA相比,净货币效益增加了11.6% (RASA-NMB = 278,324美元,而传统CEA NMB = 249,311美元)。结果对风险规避估计和患者效用的功能形式敏感。结论:在GRACE在神经病学中的首次应用中,GRACE增加了一种假设的神经病学治疗的健康经济价值,这表明TCEA可能低估了运动相关神经损伤的治疗价值。
{"title":"A Generalized Risk-Adjusted Cost-Effectiveness Economic Model for Measuring the Value of Interventions That Delay Mobility Impairment Across Neurological Conditions","authors":"Jason Shafrin PhD ,&nbsp;Jaehong Kim PhD ,&nbsp;Jacob Fajnor BA ,&nbsp;Kyi-Sin Than MPH ,&nbsp;Elizabeth S. Mearns PharmD ,&nbsp;Stacey L. Kowal MSc ,&nbsp;Thomas Majda PharmD ,&nbsp;Jakub P. Hlávka PhD","doi":"10.1016/j.jval.2025.08.006","DOIUrl":"10.1016/j.jval.2025.08.006","url":null,"abstract":"<div><h3>Objectives</h3><div>To quantify how incorporating patient risk preferences and severity adjustments affect the value of a hypothetical treatment for mobility impairments caused by neurological conditions.</div></div><div><h3>Methods</h3><div>A 5-state Markov model was developed to measure the health economic value of a hypothetical treatment delaying the progression of mobility impairments by 30.7% versus standard of care for patients who were 45-year-old, minimally impaired, and had received a diagnosis of a neurological condition. A generalized and risk-adjusted cost-effectiveness (GRACE) model was implemented using relative risk aversion estimates from a US general population survey. Treatment value was measured as risk-aversion and severity-adjusted net monetary benefit (NMB), defined as (1) risk-adjusted health gains (generalized risk-adjusted quality-adjusted life-years [GRA-QALYs]) monetized by (2) risk-aversion and severity-adjusted willingness to pay less (3) incremental costs. Risk-neutral results (traditional cost-effectiveness analysis [TCEA]) were compared.</div></div><div><h3>Results</h3><div>Incorporating risk preferences and disease severity increased the value of health benefits. Incremental health gains from using the hypothetical treatment (vs standard of care) were valued more when accounting for risk preferences with GRACE (1.358 GRA-QALYs vs 1.199 QALY). Willingness to pay for these health gains was higher when computed under GRACE compared with TCEA ($109 656 per GRA-QALY vs $100 000 per QALY). Overall, NMB increased by 11.6% (risk-aversion and severity-adjusted NMB = $278 324 vs TCEA NMB = $249 311) using GRACE versus TCEA. Results were sensitive to risk-aversion estimates and the functional form of patient utility.</div></div><div><h3>Conclusions</h3><div>In the first application of GRACE within neurology, GRACE increased the health economic value of a hypothetical neurology treatment, suggesting that TCEA may undervalue treatments for mobility-related neurological impairments.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 46-53"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144970892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining Simulation Model-Based Outcomes With County-Level Data for Geographic Health Equity Impact Evaluations of New Interventions 将基于模拟模型的结果与县级数据相结合,用于新干预措施的地理卫生公平影响评估。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.07.025
Jeroen P. Jansen PhD , Michael P. Douglas MS , Kathryn A. Phillips PhD

Objectives

Geographic health disparities persist across the United States, with substantial variations in health outcomes between regions. Evaluating how emerging health technologies might affect these disparities is crucial for developing equitable health policies. This article introduces an approach for geographic health equity impact evaluation by combining predicted outcomes by equity-relevant subgroup from a simulation model with US county-level data on subgroup proportions.

Methods

The approach involves the following steps: (1) create a data set with county-level information on equity-relevant factors and lifetime risk of the target indication; (2) estimate quality-adjusted life-years (QALYs) and costs with and without the intervention for different combinations of equity-relevant factors with the simulation model; (3) calculate expected and incremental QALYs in target population, incremental net health benefits per 100 000 general population, and quality-adjusted life expectancy at birth without and with liquid biopsy for each county based on its distribution of equity-relevant factors and step 2 estimates; and (4) quantify inequality in QALYs and quality-adjusted life expectancies between counties with and without the technology and the corresponding health equity impact.

Results

We illustrate the approach using liquid biopsy for first-line treatment in non-small cell lung cancer. Future applications should incorporate more detailed information on the equity-relevant groups by county.

Conclusions

Combining simulation model outcomes with county-level data on equity-relevant subgroups provides a novel approach for health equity impact evaluations of new interventions. It facilitates examining how introducing a new health technology can affect geographic disparities in health and can help identify areas that may benefit most from a new intervention.
目的:美国各地的地理健康差异持续存在,各地区之间的健康结果存在很大差异。评估新兴卫生技术可能如何影响这些差异,对于制定公平的卫生政策至关重要。本文介绍了一种地理健康公平影响评估方法,该方法将模拟模型中与公平相关的子组预测结果与美国县级子组比例数据相结合。方法:该方法包括以下步骤:1)创建县级股票相关因素和目标适应症终身风险信息数据集;2)利用仿真模型估计有和没有干预的不同股权相关因素组合的质量年和成本;3)根据公平相关因素的分布和第2步估计,计算每个县目标人口的预期和增量质量预期寿命、每10万普通人口的增量净健康福利,以及没有和有LB的质量调整出生预期寿命(QALEs);4)量化有技术县与无技术县在质量质量年和质量质量方面的不平等以及相应的卫生公平影响。结果:我们阐述了液体活检在非小细胞肺癌的一线治疗中的方法。未来的申请应按县纳入更多有关股权相关群体的详细信息。结论:将模拟模型结果与县级公平相关亚组数据相结合,为新干预措施的卫生公平影响评估提供了一种新方法。它有助于审查引进一项新的卫生技术如何影响卫生领域的地域差异,并有助于确定可能从一项新的干预措施中获益最多的地区。
{"title":"Combining Simulation Model-Based Outcomes With County-Level Data for Geographic Health Equity Impact Evaluations of New Interventions","authors":"Jeroen P. Jansen PhD ,&nbsp;Michael P. Douglas MS ,&nbsp;Kathryn A. Phillips PhD","doi":"10.1016/j.jval.2025.07.025","DOIUrl":"10.1016/j.jval.2025.07.025","url":null,"abstract":"<div><h3>Objectives</h3><div>Geographic health disparities persist across the United States, with substantial variations in health outcomes between regions. Evaluating how emerging health technologies might affect these disparities is crucial for developing equitable health policies. This article introduces an approach for geographic health equity impact evaluation by combining predicted outcomes by equity-relevant subgroup from a simulation model with US county-level data on subgroup proportions.</div></div><div><h3>Methods</h3><div>The approach involves the following steps: (1) create a data set with county-level information on equity-relevant factors and lifetime risk of the target indication; (2) estimate quality-adjusted life-years (QALYs) and costs with and without the intervention for different combinations of equity-relevant factors with the simulation model; (3) calculate expected and incremental QALYs in target population, incremental net health benefits per 100 000 general population, and quality-adjusted life expectancy at birth without and with liquid biopsy for each county based on its distribution of equity-relevant factors and step 2 estimates; and (4) quantify inequality in QALYs and quality-adjusted life expectancies between counties with and without the technology and the corresponding health equity impact.</div></div><div><h3>Results</h3><div>We illustrate the approach using liquid biopsy for first-line treatment in non-small cell lung cancer. Future applications should incorporate more detailed information on the equity-relevant groups by county.</div></div><div><h3>Conclusions</h3><div>Combining simulation model outcomes with county-level data on equity-relevant subgroups provides a novel approach for health equity impact evaluations of new interventions. It facilitates examining how introducing a new health technology can affect geographic disparities in health and can help identify areas that may benefit most from a new intervention.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 34-45"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144804932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes and Measures for Vaginal Relaxation Syndrome: A Systematic Review 阴道松弛综合征的临床结果和措施:系统综述。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.08.012
Hongqin Chen MD , Jian Meng MM , Qiao Li MM , Yajing Wang MM , Yueyue Chen MD , Xiaoyu Niu MD , Dongmei Wei MD

Objectives

This study systematically investigates the application of clinical outcomes and measures reported in the management of vaginal relaxation syndrome (VRS). It further analyzes and compares variations in clinical outcomes and measures across different interventions in VRS, with a focus on assessing their generalizability and applicability. The findings aim to inform the design of high-quality clinical trials and provide a foundation for developing a Core Outcome Set (COS) and a Core Outcome Measurement Set (COMS).

Methods

A systematic search of PubMed, Embase, Web of Science, and Cochrane databases (up to January 2025) identified clinical studies on VRS treatment. Two researchers independently screened studies, extracted data, and analyzed clinical outcomes, measurement tools, and assessment time points.

Results

A total of 74 studies (15 randomized controlled trials, 59 observational studies, and 4866 patients) reported 113 outcomes using 85 measurement tools. The most frequently used were patient-reported outcome measures (Female Sexual Function Index, Vaginal Laxity Questionnaire, VAS, and PISQ-12), followed by clinician-reported outcome measures (VHI and biopsy). Most follow-ups lasted under 6 months. Surgical treatments uniquely assessed recurrence, aesthetic satisfaction, and partners’ sexual satisfaction, whereas nonsurgical approaches focused on overall efficacy, tolerability, and patients satisfaction with vaginal tightness.

Conclusions

Clinical outcomes and measures for VRS are overly complex, particularly PROs. Future research should focus on optimizing PROs by developing highly feasible, practical PROMs. Delphi surveys and expert consensus could establish a comprehensive VRS-specific Core Outcome Set and Core Outcome Measurement Set, alongside standardized assessment time points, improving research consistency and evidence-based management of VRS.
目的:本研究系统地探讨了阴道松弛综合征(VRS)治疗的临床结果和措施的应用。它进一步分析和比较了VRS中不同干预措施的临床结果和措施的差异,重点是评估其普遍性和适用性。研究结果旨在为高质量临床试验的设计提供信息,并为制定核心结果集(COS)和核心结果测量集(COMS)提供基础。方法:系统检索PubMed、Embase、Web of Science和Cochrane数据库(截至2025年1月),确定VRS治疗的临床研究。两名研究人员独立筛选研究,提取数据,分析临床结果、测量工具和评估时间点。结果:74项研究(15项随机对照试验,59项观察性研究,4866例患者)使用85种测量工具报告了113项结果。最常用的是患者报告的结果测量(FSFI, VLQ, VAS, PISQ-12),其次是临床报告的结果测量(VHI,活检)。大多数随访持续不到6个月。手术治疗独特地评估复发率、审美满意度和性伴侣的性满意度,而非手术方法侧重于总体疗效、耐受性和患者对阴道紧绷度的满意度。结论:VRS的临床结果和措施过于复杂,尤其是PROs。未来的研究应侧重于通过开发高度可行、实用的prom来优化pro。德尔菲调查和专家共识可以建立全面的VRS特异性COS和COMS,以及标准化的评估时间点,提高VRS研究的一致性和循证管理。
{"title":"Clinical Outcomes and Measures for Vaginal Relaxation Syndrome: A Systematic Review","authors":"Hongqin Chen MD ,&nbsp;Jian Meng MM ,&nbsp;Qiao Li MM ,&nbsp;Yajing Wang MM ,&nbsp;Yueyue Chen MD ,&nbsp;Xiaoyu Niu MD ,&nbsp;Dongmei Wei MD","doi":"10.1016/j.jval.2025.08.012","DOIUrl":"10.1016/j.jval.2025.08.012","url":null,"abstract":"<div><h3>Objectives</h3><div>This study systematically investigates the application of clinical outcomes and measures reported in the management of vaginal relaxation syndrome (VRS). It further analyzes and compares variations in clinical outcomes and measures across different interventions in VRS, with a focus on assessing their generalizability and applicability. The findings aim to inform the design of high-quality clinical trials and provide a foundation for developing a Core Outcome Set (COS) and a Core Outcome Measurement Set (COMS).</div></div><div><h3>Methods</h3><div>A systematic search of PubMed, Embase, Web of Science, and Cochrane databases (up to January 2025) identified clinical studies on VRS treatment. Two researchers independently screened studies, extracted data, and analyzed clinical outcomes, measurement tools, and assessment time points.</div></div><div><h3>Results</h3><div>A total of 74 studies (15 randomized controlled trials, 59 observational studies, and 4866 patients) reported 113 outcomes using 85 measurement tools. The most frequently used were patient-reported outcome measures (Female Sexual Function Index, Vaginal Laxity Questionnaire, VAS, and PISQ-12), followed by clinician-reported outcome measures (VHI and biopsy). Most follow-ups lasted under 6 months. Surgical treatments uniquely assessed recurrence, aesthetic satisfaction, and partners’ sexual satisfaction, whereas nonsurgical approaches focused on overall efficacy, tolerability, and patients satisfaction with vaginal tightness.</div></div><div><h3>Conclusions</h3><div>Clinical outcomes and measures for VRS are overly complex, particularly PROs. Future research should focus on optimizing PROs by developing highly feasible, practical PROMs. Delphi surveys and expert consensus could establish a comprehensive VRS-specific Core Outcome Set and Core Outcome Measurement Set, alongside standardized assessment time points, improving research consistency and evidence-based management of VRS.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 149-158"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144993314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Head-to-Head Comparison of the Psychometric Properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, and CHU9D in Children Aged 8 to 18 Years With Eczema EQ-5D-Y-3L、EQ-5D-Y-5L和CHU9D对8-18岁湿疹患儿心理测量特性的正面比较
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.07.021
Rachel Lee-Yin Tan BA , Jian Yi Soh MMed , Elizabeth Huiwen Tham MMed , Anne Eng Neo Goh MMed , Mark Jean Aan Koh MMed , Nisha Suyien Chandran MMed , Madeline Sheun Ling Ho MMed , Lucinda Siyun Tan MMed , Michael Herdman MSc , Nan Luo PhD

Objectives

This study evaluated and compared the psychometric properties (ceiling effects, construct validity, and responsiveness) of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and child health utility 9D (CHU9D) in pediatric patients with eczema.

Methods

Patients completed the Y-3L, Y-5L, CHU9D, and the Child Dermatology Life Quality Index and were followed up during their next visit. Clinicians assessed patients’ skin status using the Validated Investigator Global Assessment scale for Atopic Dermatitis. Ceiling effects of the 3 instruments were compared. Convergent validity was assessed using correlation with the Child Dermatology Life Quality Index; known-group validity was evaluated using F-statistics; and responsiveness was assessed using standardized effect sizes (SESs) among patients reporting improved health.

Results

A total of 164 patients (mean age: 12.2 years; female: 47.6%) participated in the study. Of those, 67 patients (mean age:11.9; female: 53.8%) completed the follow-up survey. The ceiling effects of Y-3L, Y-5L, and CHU9D were 34.8%, 28.7%, and 9.8%, respectively. All known-group hypotheses, defined by the Validated Investigator Global Assessment scale for Atopic Dermatitis and scratching frequency, were met, with Y-5L showing the strongest performance in discriminating between patients based on symptom severity. Convergent validity was met in 70.0%, 70.0%, and 83.3% of hypotheses tested for Y-3L, Y-5L, and CHU9D, respectively. CHU9D (SES = 0.53) was relatively more responsive to change than Y-3L (SES= 0.18) or Y-5L (SES = 0.43).

Conclusions

Y-3L and Y-5L were more sensitive to clinical outcome differences, whereas CHU9D appeared to be more responsive to self-rated health improvement. Further research using clinical measures and more diverse eczema patient samples is needed to confirm these findings and support evidence-based instrument selection.
目的:本研究评估并比较了EQ-5D-Y-3L (Y-3L)、EQ-5D-Y-5L (Y-5L)和CHU9D在儿科湿疹患者中的心理测量特性(天花板效应、结构效度和反应性)。方法:患者完成Y-3L、Y-5L、CHU9D和儿童皮肤病生活质量指数(CDLQI),并在下次就诊时进行随访。临床医生使用经过验证的特应性皮炎研究者全球评估量表(vIGA-AD)评估患者的皮肤状况。比较了三种仪器的天花板效应。采用与CDLQI的相关性评估收敛效度;使用f统计量评估已知组效度;在报告健康状况改善的患者中,使用标准化效应量(SES)评估反应性。结果:共164例患者,平均年龄12.2岁;女性:47.6%)参与了研究。其中67例患者(平均年龄11.9岁;女性:53.8%)完成了随访调查。Y-3L、Y-5L和CHU9D的天花板效应分别为34.8%、28.7%和9.8%。所有已知组假设(由vIGA-AD和抓挠频率定义)均得到满足,Y-5L在根据症状严重程度区分患者方面表现出最强的表现。Y-3L、Y-5L和CHU9D的趋同效度分别为70%、70%和83.3%。CHU9D (SES= 0.52)对变化的反应比Y-3L (SES= 0.18)或Y-5L (SES= 0.43)稍强。结论:Y-3L和Y-5L对临床结果差异更敏感,而CHU9D对自评健康改善更敏感。需要使用临床测量和更多样化的湿疹患者样本进行进一步的研究来证实这些发现并支持基于证据的工具选择。
{"title":"A Head-to-Head Comparison of the Psychometric Properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, and CHU9D in Children Aged 8 to 18 Years With Eczema","authors":"Rachel Lee-Yin Tan BA ,&nbsp;Jian Yi Soh MMed ,&nbsp;Elizabeth Huiwen Tham MMed ,&nbsp;Anne Eng Neo Goh MMed ,&nbsp;Mark Jean Aan Koh MMed ,&nbsp;Nisha Suyien Chandran MMed ,&nbsp;Madeline Sheun Ling Ho MMed ,&nbsp;Lucinda Siyun Tan MMed ,&nbsp;Michael Herdman MSc ,&nbsp;Nan Luo PhD","doi":"10.1016/j.jval.2025.07.021","DOIUrl":"10.1016/j.jval.2025.07.021","url":null,"abstract":"<div><h3>Objectives</h3><div>This study evaluated and compared the psychometric properties (ceiling effects, construct validity, and responsiveness) of EQ-5D-Y-3L (Y-3L), EQ-5D-Y-5L (Y-5L), and child health utility 9D (CHU9D) in pediatric patients with eczema.</div></div><div><h3>Methods</h3><div>Patients completed the Y-3L, Y-5L, CHU9D, and the Child Dermatology Life Quality Index and were followed up during their next visit. Clinicians assessed patients’ skin status using the Validated Investigator Global Assessment scale for Atopic Dermatitis. Ceiling effects of the 3 instruments were compared. Convergent validity was assessed using correlation with the Child Dermatology Life Quality Index; known-group validity was evaluated using F-statistics; and responsiveness was assessed using standardized effect sizes (SESs) among patients reporting improved health.</div></div><div><h3>Results</h3><div>A total of 164 patients (mean age: 12.2 years; female: 47.6%) participated in the study. Of those, 67 patients (mean age:11.9; female: 53.8%) completed the follow-up survey. The ceiling effects of Y-3L, Y-5L, and CHU9D were 34.8%, 28.7%, and 9.8%, respectively. All known-group hypotheses, defined by the Validated Investigator Global Assessment scale for Atopic Dermatitis and scratching frequency, were met, with Y-5L showing the strongest performance in discriminating between patients based on symptom severity. Convergent validity was met in 70.0%, 70.0%, and 83.3% of hypotheses tested for Y-3L, Y-5L, and CHU9D, respectively. CHU9D (SES = 0.53) was relatively more responsive to change than Y-3L (SES= 0.18) or Y-5L (SES = 0.43).</div></div><div><h3>Conclusions</h3><div>Y-3L and Y-5L were more sensitive to clinical outcome differences, whereas CHU9D appeared to be more responsive to self-rated health improvement. Further research using clinical measures and more diverse eczema patient samples is needed to confirm these findings and support evidence-based instrument selection.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 100-107"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144800396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Adolescent and Adult Preferences for EQ-5D-Y-3L Health States in Hong Kong 比较香港青少年和成人对EQ-5D-Y-3L健康状况的偏好。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2026-01-01 DOI: 10.1016/j.jval.2025.08.005
Kailu Wang BMed, PhD , Oliver Rivero-Arias MSc, DPhil , Annie Wai-Ling Cheung MPhil , Amy Yuen-Kwan Wong MSc , Eng-Kiong Yeoh MBBS , Eliza Lai-Yi Wong BSN, MPH, PhD

Objectives

The EuroQol EQ-5D-Y-3L valuation protocol suggests eliciting adult preferences from the perspective of a 10-year-old child. However, further research on whether it is feasible to elicit adolescent preferences for EQ-5D-Y-3L health states and how adolescent preferences compare with adult preferences is needed. This study aimed to compare preferences for EQ-5D-Y-3L health states and survey response behaviors between adolescents and adults in the general population of Hong Kong.

Methods

Cross-sectional face-to-face surveys were conducted between December 2018 and July 2023 with adolescents and adults in Hong Kong. Discrete choice experiments (DCEs) were used to elicit adolescent preferences from their own perspective and adult preferences from a 10-year-old child’s perspective for EQ-5D-Y-3L health states. Mixed logit models estimated the relative importance attribute levels for comparison between adolescents and adults using separate models for each group or a pooled model combining responses. Survey response behaviors were also analyzed by comparing the dominant task responses and feedback to DCE tasks between adolescents and adults.

Results

DCE responses from 776 adolescents aged 12 to 17 years and 1001 adults were used in the analysis after exclusions. For both groups, the most important dimension was pain/discomfort, followed by worried/sad/unhappy, usual activities, mobility, and self-care. Adolescents placed greater importance on mobility and self-care, while valuing pain/discomfort and usual activities less. Significant differences in relative importance of levels across all dimensions between the 2 groups were observed.

Conclusions

Adolescents showed different preference weightings compared with adults but reported greater challenges in completing the DCE tasks. These findings suggest that including adolescents in the valuation of EQ-5D-Y-3L health state is feasible; however, data provided by this group can be of lower data quality than adults.
目的:EuroQol EQ-5D-Y-3L评价方案建议从10岁儿童的角度引出成人的偏好。然而,是否可以诱导青少年对EQ-5D-Y-3L健康状态的偏好,以及青少年偏好与成人偏好的比较,还需要进一步的研究。本研究旨在比较香港青少年和成人对EQ-5D-Y-3L健康状态的偏好和调查反应行为。方法:2018年12月至2023年7月,对香港青少年和成年人进行横断面面对面调查。采用离散选择实验(DCEs),分别从青少年和成人的角度对EQ-5D-Y-3L健康状态进行选择。混合logit模型估计了青少年和成年人之间比较的相对重要属性水平,使用每组单独的模型或组合响应的混合模型。通过比较青少年和成人的主导任务反应和对DCE任务的反馈,分析调查反应行为。结果:排除后,776名12-17岁青少年和1001名成年人的DCE应答被用于分析。对于这两组人来说,最重要的维度是疼痛/不适,其次是担心/悲伤/不快乐、日常活动、流动性和自我保健。青少年更重视活动能力和自我保健,而不太重视疼痛/不适和日常活动。观察到两组之间所有维度水平的相对重要性存在显著差异。结论:与成年人相比,青少年表现出不同的偏好权重,但在完成DCE任务时报告了更大的挑战。这些发现表明,将青少年纳入EQ-5D-Y-3L健康状态评估是可行的,但该群体提供的数据质量可能低于成人。
{"title":"Comparing Adolescent and Adult Preferences for EQ-5D-Y-3L Health States in Hong Kong","authors":"Kailu Wang BMed, PhD ,&nbsp;Oliver Rivero-Arias MSc, DPhil ,&nbsp;Annie Wai-Ling Cheung MPhil ,&nbsp;Amy Yuen-Kwan Wong MSc ,&nbsp;Eng-Kiong Yeoh MBBS ,&nbsp;Eliza Lai-Yi Wong BSN, MPH, PhD","doi":"10.1016/j.jval.2025.08.005","DOIUrl":"10.1016/j.jval.2025.08.005","url":null,"abstract":"<div><h3>Objectives</h3><div>The EuroQol EQ-5D-Y-3L valuation protocol suggests eliciting adult preferences from the perspective of a 10-year-old child. However, further research on whether it is feasible to elicit adolescent preferences for EQ-5D-Y-3L health states and how adolescent preferences compare with adult preferences is needed. This study aimed to compare preferences for EQ-5D-Y-3L health states and survey response behaviors between adolescents and adults in the general population of Hong Kong.</div></div><div><h3>Methods</h3><div>Cross-sectional face-to-face surveys were conducted between December 2018 and July 2023 with adolescents and adults in Hong Kong. Discrete choice experiments (DCEs) were used to elicit adolescent preferences from their own perspective and adult preferences from a 10-year-old child’s perspective for EQ-5D-Y-3L health states. Mixed logit models estimated the relative importance attribute levels for comparison between adolescents and adults using separate models for each group or a pooled model combining responses. Survey response behaviors were also analyzed by comparing the dominant task responses and feedback to DCE tasks between adolescents and adults.</div></div><div><h3>Results</h3><div>DCE responses from 776 adolescents aged 12 to 17 years and 1001 adults were used in the analysis after exclusions. For both groups, the most important dimension was pain/discomfort, followed by worried/sad/unhappy, usual activities, mobility, and self-care. Adolescents placed greater importance on mobility and self-care, while valuing pain/discomfort and usual activities less. Significant differences in relative importance of levels across all dimensions between the 2 groups were observed.</div></div><div><h3>Conclusions</h3><div>Adolescents showed different preference weightings compared with adults but reported greater challenges in completing the DCE tasks. These findings suggest that including adolescents in the valuation of EQ-5D-Y-3L health state is feasible; however, data provided by this group can be of lower data quality than adults.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"29 1","pages":"Pages 139-148"},"PeriodicalIF":6.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144970743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Societal Preferences for Priority by Disease Severity in England and Wales. 了解英格兰和威尔士社会对疾病严重程度优先级的偏好。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2025-12-30 DOI: 10.1016/j.jval.2025.12.011
Helen Hayes, Priscila Radu, David J Mott, Chris Skedgel

Objectives: A number of health technology assessment bodies, including the National Institute for Health and Care Excellence (NICE), have introduced "severity modifiers" that assign greater value to health gains to patients with greater health shortfalls. Such modifiers are consistent with qualitative societal values, but their alignment with quantitative strength of preference among the public is not clear. We sought to understand quantitative preferences over severity in England and Wales, relative to NICE's severity modifier.

Methods: We elicited person trade-off weights, severity cutoffs, and attitudinal questions to understand the range of public concern for severity and the additional weight (if any) given to health gains for patients with greater health shortfalls. The questionnaire was developed via qualitative interviews and administered to a representative sample of the public in England and Wales. Severity was defined in terms of proportional and absolute health shortfall.

Results: Based on 990 complete-case responses, we find that the median value of health gains to patients in more-severe health states increases over the lower range of health shortfall and plateaus beyond 65% proportional health shortfall. The person trade-off value function and stated severity cutoffs suggest public concern for severity extends beyond NICE's current range. Our absolute health shortfall results are not directly comparable to NICE's discounted cutoffs.

Conclusions: Societal concern for severity appears to begin at substantially lower shortfalls, and the relative value of health gains is greater at almost every level of severity, than NICE's current modifier. Further research will be required to confirm this interpretation, especially in understanding preferences for older or younger reference ages and incorporating NICE's discounting of shortfall.

目标:包括NICE在内的一些HTA机构引入了“严重程度调节剂”,为健康状况更差的患者的健康收益赋予更大的价值。这些修饰词与定性的社会价值观是一致的,但它们与公众偏好的定量强度的一致性并不清楚。我们试图了解英格兰和威尔士相对于NICE的严重性修饰符对严重性的定量偏好。方法:我们引出了个人权衡(PTO)权重、严重程度临界值和态度问题,以了解公众对严重程度的关注范围,以及对健康状况更差的患者的健康收益给予的额外权重(如果有的话)。调查问卷是通过定性访谈制定的,并对英格兰和威尔士有代表性的公众样本进行了管理。严重程度是根据比例(PS)和绝对(AS)健康不足来定义的。结果:基于990个完整病例的回复,我们发现病情较重的患者的健康收益中位数在健康不足的较低范围内增加,而在65% PS以上处于稳定状态。PTO值函数和规定的严重程度临界值表明,公众对严重程度的关注超出了NICE目前的范围。我们的AS结果不能直接与NICE的贴现截止值进行比较。结论:社会对严重程度的关注似乎从低得多的缺口开始,并且在几乎每个严重程度上,健康收益的相对价值都比NICE目前的修正值更大。需要进一步的研究来证实这一解释,特别是在理解对更大或更小参考年龄的偏好和纳入NICE对不足的折扣方面。
{"title":"Understanding Societal Preferences for Priority by Disease Severity in England and Wales.","authors":"Helen Hayes, Priscila Radu, David J Mott, Chris Skedgel","doi":"10.1016/j.jval.2025.12.011","DOIUrl":"10.1016/j.jval.2025.12.011","url":null,"abstract":"<p><strong>Objectives: </strong>A number of health technology assessment bodies, including the National Institute for Health and Care Excellence (NICE), have introduced \"severity modifiers\" that assign greater value to health gains to patients with greater health shortfalls. Such modifiers are consistent with qualitative societal values, but their alignment with quantitative strength of preference among the public is not clear. We sought to understand quantitative preferences over severity in England and Wales, relative to NICE's severity modifier.</p><p><strong>Methods: </strong>We elicited person trade-off weights, severity cutoffs, and attitudinal questions to understand the range of public concern for severity and the additional weight (if any) given to health gains for patients with greater health shortfalls. The questionnaire was developed via qualitative interviews and administered to a representative sample of the public in England and Wales. Severity was defined in terms of proportional and absolute health shortfall.</p><p><strong>Results: </strong>Based on 990 complete-case responses, we find that the median value of health gains to patients in more-severe health states increases over the lower range of health shortfall and plateaus beyond 65% proportional health shortfall. The person trade-off value function and stated severity cutoffs suggest public concern for severity extends beyond NICE's current range. Our absolute health shortfall results are not directly comparable to NICE's discounted cutoffs.</p><p><strong>Conclusions: </strong>Societal concern for severity appears to begin at substantially lower shortfalls, and the relative value of health gains is greater at almost every level of severity, than NICE's current modifier. Further research will be required to confirm this interpretation, especially in understanding preferences for older or younger reference ages and incorporating NICE's discounting of shortfall.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145889787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accounting for the Scarcity of Time as Patients Approach End of Life: The Construction of End-Weighted Time Toxicity. 考虑到病人接近生命终点时时间的稀缺:终点加权时间毒性的构建。
IF 6 2区 医学 Q1 ECONOMICS Pub Date : 2025-12-26 DOI: 10.1016/j.jval.2025.12.010
Juliet Jacobsen, Sanjoy Mahajan, Joakim Ekstrand, Karin Boo Hammas, Peter May, Jenny Klintman

Objectives: People with serious illness approaching end of life often end up in emergency and hospital care, frequently against expressed preferences. Consequently, oncology trials record care days as a measure of treatment burden called "time toxicity." However, this measure ignores the diminishing marginal utility of time: that the value of a day is higher when fewer remain. We aimed to incorporate this relationship into time toxicity.

Methods: We derived a preference-independent time-toxicity metric sensitive to time remaining, end-weighted time toxicity. It has units of toxiles and is based on the fraction of the patient's remaining time taken up by a care visit. We trialed this metric in a cohort of Swedish cancer patients referred to palliative care.

Results: There were 192 patients in the cohort; 146 (76%) eventually enrolled in palliative care. In the cohort, mean (SD, skewness) and median (IQR) end-weighted time toxicities were 0.63 (0.89, 1.77) and 0.23 (0.03-0.81) toxiles. End-weighted time toxicity was significantly less for the group eventually enrolled in palliative care (0.52 [0.75] and 0.22 [0.04-0.63] toxiles) than for the never enrolled group (0.97 [1.18] and 0.27 [0.27-1.76] toxiles) (P = .024). A time-series analysis showed that total toxicity in never- or not-yet-enrolled patients was 120.2 toxiles, whereas total toxicity in already-enrolled patients was 1.0 toxiles.

Conclusions: A healthcare metric that incorporates diminishing marginal utility of time can highlight the effect of palliative care and could improve resource allocation and patient satisfaction with care near end of life. Further research should explore stakeholder perspectives and practical applications.

目的:患有严重疾病接近生命终点的人往往最终在紧急和医院护理,经常违背自己的意愿。因此,肿瘤试验记录护理天数作为治疗负担的衡量标准,称为“时间毒性”。然而,这种方法忽略了时间的边际效用递减:当时间越少,一天的价值就越高。我们的目标是将这种关系整合到时间毒性中。方法:我们推导了一个独立于偏好的时间毒性指标,对剩余时间敏感,终点加权时间毒性。它以toxiles为单位,并基于病人剩余时间中护理访问所占的比例。我们在一组接受姑息治疗的瑞典癌症患者中试验了这一指标。结果:队列中有192例患者;146例(76%)最终接受了姑息治疗。在队列中,平均(SD,偏度)和中位(IQR)终点加权时间毒性分别为0.63(0.89,1.77)和0.23(0.03-0.81)个毒虫。最终纳入缓和治疗组的终末加权时间毒性[0.52(0.75)和0.22 (0.04-0.63)toxiles]明显低于未纳入组[0.97(1.18)和0.27 (0.27-1.76)toxiles] (p=0.024)。时间序列分析显示,未入组或未入组患者的总毒性为120.2个毒素,而已入组患者的总毒性为1.0个毒素。结论:纳入时间边际效用递减的医疗保健指标可以突出姑息治疗的效果,并可以改善资源分配和患者对临终护理的满意度。进一步的研究应探索利益相关者的观点和实际应用。
{"title":"Accounting for the Scarcity of Time as Patients Approach End of Life: The Construction of End-Weighted Time Toxicity.","authors":"Juliet Jacobsen, Sanjoy Mahajan, Joakim Ekstrand, Karin Boo Hammas, Peter May, Jenny Klintman","doi":"10.1016/j.jval.2025.12.010","DOIUrl":"10.1016/j.jval.2025.12.010","url":null,"abstract":"<p><strong>Objectives: </strong>People with serious illness approaching end of life often end up in emergency and hospital care, frequently against expressed preferences. Consequently, oncology trials record care days as a measure of treatment burden called \"time toxicity.\" However, this measure ignores the diminishing marginal utility of time: that the value of a day is higher when fewer remain. We aimed to incorporate this relationship into time toxicity.</p><p><strong>Methods: </strong>We derived a preference-independent time-toxicity metric sensitive to time remaining, end-weighted time toxicity. It has units of toxiles and is based on the fraction of the patient's remaining time taken up by a care visit. We trialed this metric in a cohort of Swedish cancer patients referred to palliative care.</p><p><strong>Results: </strong>There were 192 patients in the cohort; 146 (76%) eventually enrolled in palliative care. In the cohort, mean (SD, skewness) and median (IQR) end-weighted time toxicities were 0.63 (0.89, 1.77) and 0.23 (0.03-0.81) toxiles. End-weighted time toxicity was significantly less for the group eventually enrolled in palliative care (0.52 [0.75] and 0.22 [0.04-0.63] toxiles) than for the never enrolled group (0.97 [1.18] and 0.27 [0.27-1.76] toxiles) (P = .024). A time-series analysis showed that total toxicity in never- or not-yet-enrolled patients was 120.2 toxiles, whereas total toxicity in already-enrolled patients was 1.0 toxiles.</p><p><strong>Conclusions: </strong>A healthcare metric that incorporates diminishing marginal utility of time can highlight the effect of palliative care and could improve resource allocation and patient satisfaction with care near end of life. Further research should explore stakeholder perspectives and practical applications.</p>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":" ","pages":""},"PeriodicalIF":6.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Value in Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1